Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2023-04-01
|
| Series: | Blood Cancer Journal |
| Online Access: | https://doi.org/10.1038/s41408-023-00824-8 |
| _version_ | 1827966462624530432 |
|---|---|
| author | Ahmad Alcheikh Griffith B. Perkins Phillippa A. Pucar Amelia Cecchin Cheng Sheng Chai Matthew Tunbridge Anouschka Akerman Anupriya Aggarwal Vanessa Milogiannakis Stuart Turville Sharon Allen Pravin Hissaria Tatjana Banovic P. Toby Coates David M. Ross |
| author_facet | Ahmad Alcheikh Griffith B. Perkins Phillippa A. Pucar Amelia Cecchin Cheng Sheng Chai Matthew Tunbridge Anouschka Akerman Anupriya Aggarwal Vanessa Milogiannakis Stuart Turville Sharon Allen Pravin Hissaria Tatjana Banovic P. Toby Coates David M. Ross |
| author_sort | Ahmad Alcheikh |
| collection | DOAJ |
| first_indexed | 2024-04-09T17:49:12Z |
| format | Article |
| id | doaj.art-5ebac46f606c4865894a95817529e690 |
| institution | Directory Open Access Journal |
| issn | 2044-5385 |
| language | English |
| last_indexed | 2024-04-09T17:49:12Z |
| publishDate | 2023-04-01 |
| publisher | Nature Publishing Group |
| record_format | Article |
| series | Blood Cancer Journal |
| spelling | doaj.art-5ebac46f606c4865894a95817529e6902023-04-16T11:07:18ZengNature Publishing GroupBlood Cancer Journal2044-53852023-04-011311410.1038/s41408-023-00824-8Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patientsAhmad Alcheikh0Griffith B. Perkins1Phillippa A. Pucar2Amelia Cecchin3Cheng Sheng Chai4Matthew Tunbridge5Anouschka Akerman6Anupriya Aggarwal7Vanessa Milogiannakis8Stuart Turville9Sharon Allen10Pravin Hissaria11Tatjana Banovic12P. Toby Coates13David M. Ross14Department of Haematology, Royal Adelaide HospitalCentral and Northern Adelaide Renal and Transplantation Service, Royal Adelaide HospitalImmunology Directorate, SA PathologyImmunology Directorate, SA PathologyAdelaide Medical School, University of AdelaideCentral and Northern Adelaide Renal and Transplantation Service, Royal Adelaide HospitalKirby Institute, University of New South WalesKirby Institute, University of New South WalesKirby Institute, University of New South WalesKirby Institute, University of New South WalesDepartment of Haematology, Royal Adelaide HospitalCentral and Northern Adelaide Renal and Transplantation Service, Royal Adelaide HospitalImmunology Directorate, SA PathologyCentral and Northern Adelaide Renal and Transplantation Service, Royal Adelaide HospitalDepartment of Haematology, Royal Adelaide Hospitalhttps://doi.org/10.1038/s41408-023-00824-8 |
| spellingShingle | Ahmad Alcheikh Griffith B. Perkins Phillippa A. Pucar Amelia Cecchin Cheng Sheng Chai Matthew Tunbridge Anouschka Akerman Anupriya Aggarwal Vanessa Milogiannakis Stuart Turville Sharon Allen Pravin Hissaria Tatjana Banovic P. Toby Coates David M. Ross Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients Blood Cancer Journal |
| title | Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients |
| title_full | Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients |
| title_fullStr | Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients |
| title_full_unstemmed | Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients |
| title_short | Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients |
| title_sort | humoral and cellular immunity to sars cov 2 ancestral and omicron ba 5 variants following vaccination in myelofibrosis patients |
| url | https://doi.org/10.1038/s41408-023-00824-8 |
| work_keys_str_mv | AT ahmadalcheikh humoralandcellularimmunitytosarscov2ancestralandomicronba5variantsfollowingvaccinationinmyelofibrosispatients AT griffithbperkins humoralandcellularimmunitytosarscov2ancestralandomicronba5variantsfollowingvaccinationinmyelofibrosispatients AT phillippaapucar humoralandcellularimmunitytosarscov2ancestralandomicronba5variantsfollowingvaccinationinmyelofibrosispatients AT ameliacecchin humoralandcellularimmunitytosarscov2ancestralandomicronba5variantsfollowingvaccinationinmyelofibrosispatients AT chengshengchai humoralandcellularimmunitytosarscov2ancestralandomicronba5variantsfollowingvaccinationinmyelofibrosispatients AT matthewtunbridge humoralandcellularimmunitytosarscov2ancestralandomicronba5variantsfollowingvaccinationinmyelofibrosispatients AT anouschkaakerman humoralandcellularimmunitytosarscov2ancestralandomicronba5variantsfollowingvaccinationinmyelofibrosispatients AT anupriyaaggarwal humoralandcellularimmunitytosarscov2ancestralandomicronba5variantsfollowingvaccinationinmyelofibrosispatients AT vanessamilogiannakis humoralandcellularimmunitytosarscov2ancestralandomicronba5variantsfollowingvaccinationinmyelofibrosispatients AT stuartturville humoralandcellularimmunitytosarscov2ancestralandomicronba5variantsfollowingvaccinationinmyelofibrosispatients AT sharonallen humoralandcellularimmunitytosarscov2ancestralandomicronba5variantsfollowingvaccinationinmyelofibrosispatients AT pravinhissaria humoralandcellularimmunitytosarscov2ancestralandomicronba5variantsfollowingvaccinationinmyelofibrosispatients AT tatjanabanovic humoralandcellularimmunitytosarscov2ancestralandomicronba5variantsfollowingvaccinationinmyelofibrosispatients AT ptobycoates humoralandcellularimmunitytosarscov2ancestralandomicronba5variantsfollowingvaccinationinmyelofibrosispatients AT davidmross humoralandcellularimmunitytosarscov2ancestralandomicronba5variantsfollowingvaccinationinmyelofibrosispatients |